Top 20 of Paralysis

Article title # Publications/# Citations

HTLV-I associated myelopathy, a new clinical entity.

1986: HAmitani; AIgata; NIjichi; SIzumo; MMatsumoto; MOsame; MTara; KUsuku;

381

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.

2005: Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group; CACrowther; JEHiller; WSJeffries; AJMcPhee; JRMoss; JSRobinson;

183

Instant neural control of a movement signal.

2002: JPDonoghue; MRFellows; NGHatsopoulos; LPaninski; MDSerruya;

180

Conditional modification of behavior in Drosophila by targeted expression of a temperature-sensitive shibire allele in defined neurons.

2001: TKitamoto;

171

A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.

1983: JAicardi; KDias; BHagberg; ORamos;

139

Tetrodotoxin-resistant electric activity in presynaptic terminals.

1969: BKatz; RMiledi;

136

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

2002: MBravo; EMHur; DJMitchell; JCPatarroyo; JLRadosevich; PJRuiz; RASobel; LSteinman; ... OStuve; SYoussef; SSZamvil;

134

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

2008: AVAndjelkovic; TJCarlson; MAKroenke; BMSegal;

130

Cognitive control signals for neural prosthetics.

2004: RAAndersen; BDCorneil; BGreger; SMusallam; HScherberger;

119

Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke.

2005: PCelnik; LGCohen; AFlöel; CGerloff; PGiraux; FHummel; WHWu;

111

Role of Drosophila Rab5 during endosomal trafficking at the synapse and evoked neurotransmitter release.

2003: MGonzález-Gaitán; MWilsch-Bräuninger; TWucherpfennig;

111

TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.

2010: CCeuterick-De Groote; ICuijt; JJanssens; GJoris; GKleinberger; SKumar-Singh; SPereson; VSmits; CVan Broeckhoven; HWils;

109

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

2003: RAdolfsson; AAl-Chalabi; PMAndersen; JAndersson; TAwata; LBeckman; SBornes; PCarmeliet; ... DCollen; JDel-Favero; FDesmet; MDewerchin; VHansen; SKatayama; DLambrechts; LLang-Lazdunski; NLeigh; SLMarklund; LMoons; MMorimoto; KEMorrison; RMusson; HSPall; HPrats; WRobberecht; PRutgeerts; CShaw; EStorkebaum; VThijs; CVan Broeckhoven; Ivan Marion; SVermeire; RVlietinck; SWyns;

107

Autoimmune response to acetylcholine receptor.

1973: JLindström; JPatrick;

104

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1964: JOlszewski; JCRichardson; JCSteele;

104

Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.

1986: FAEl-Zaatari; JOFleming; SAStohlman; MDTrousdale; LPWeiner;

98

The contribution of muscle afferents to kinaesthesia shown by vibration induced illusions of movement and by the effects of paralysing joint afferents.

1972: GMGoodwin; PBMatthews; DIMcCloskey;

97

Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila.

1996: DDHurd; WMSaxton;

94

Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.

2007: LHComley; THGillingwater; LMMurray; NParkinson; KTalbot; DThomson;

93

Direct control of paralysed muscles by cortical neurons.

2008: EEFetz; CTMoritz; SIPerlmutter;

87